Coronary inflammation and cardiovascular risk in breast cancer after radiotherapy
Kotanidis CP. et al, (2025), European Heart Journal
Beta-Blocker Therapy after Acute Myocardial Infarction — To Block or Not to Block?
Kotanidis CP. et al, (2025), New England Journal of Medicine, 392, 1234 - 1236
Early Versus Delayed Invasive Management of Female Patients With Non–ST-Elevation Acute Coronary Syndrome: An Individual Patient Data Meta-Analysis
Mills GB. et al, (2025), Circulation: Cardiovascular Interventions
Benchmarking Photon-Counting Computed Tomography Angiography Against Invasive Assessment of Coronary Stenosis: Implications for Severely Calcified Coronaries.
Kotronias RA. et al, (2025), JACC Cardiovasc Imaging
Older women with non-ST-elevation acute coronary syndrome undergoing invasive or conservative management: an individual patient data meta-analysis.
Rubino F. et al, (2024), Eur Heart J Open, 4
Novel diagnostic approaches and management of coronary microvascular dysfunction.
Pompei G. et al, (2024), Am J Prev Cardiol, 19
Inflammatory risk and cardiovascular events in patients without obstructive coronary artery disease: the ORFAN multicentre, longitudinal cohort study.
Chan K. et al, (2024), Lancet, 403, 2606 - 2618
Invasive vs. conservative management of older patients with non-ST-elevation acute coronary syndrome: individual patient data meta-analysis
Kotanidis CP. et al, (2024), European Heart Journal, 45, 2052 - 2062
Role of Human Epicardial Adipose Tissue-Derived miR-92a-3p in Myocardial Redox State.
Carena MC. et al, (2023), J Am Coll Cardiol, 82, 317 - 332
Deep-Learning for Epicardial Adipose Tissue Assessment With Computed Tomography: Implications for Cardiovascular Risk Prediction.
West HW. et al, (2023), JACC Cardiovasc Imaging, 16, 800 - 816
Genetic variability of lipoprotein(a) controls vascular inflammation/redox signalling and predicts adverse cardiovascular outcomes in coronary artery disease N.
Polkinghorne MD. et al, (2023), EUROPEAN HEART JOURNAL, 44
GENETIC VARIABILITY OF LIPOPROTEIN(A) CONTROLS VASCULAR INFLAMMATION/REDOX SIGNALLING AND PREDICTS ADVERSE CARDIOVASCULAR OUTCOMES IN CORONARY ARTERY DISEASE
Polkinghorne M. et al, (2023), ATHEROSCLEROSIS, 379
THE ROLE OF CTA RADIOTRANSCRIPTOMIC PHENOTYPING IN UNDERSTANDING THE VASCULAR EFFECTS OF LP(A) IN ADVANCED ATHEROSCLEROSIS
Xie C. et al, (2023), HEART, 109, A270 - A271
Surgical treatment of endometrioid endometrial carcinoma - laparotomy versus laparoscopy.
Baum S. et al, (2022), J Turk Ger Gynecol Assoc, 23, 233 - 240
Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19.
Kotanidis CP. et al, (2022), Lancet Digit Health, 4, e705 - e716
Stratifying the risk in chronic coronary syndromes: a ray of hope for ischaemia?
Kotanidis CP. and Nikolaidou C., (2022), Eur J Prev Cardiol, 29, 404 - 406
Adipose Tissue Derived Ceramides Regulate the Myocardial Redox State and Predict Cardiovascular Outcomes
Polkinghorne MD. et al, (2022), CIRCULATION, 146